Observational / CohortiVNSn = 28

Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study

Shikora SA, Toouli J, Herrera MF, Kulseng B, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, et al.

Obesity Surgery · 2016

Key finding

In 28 obese type 2 diabetic subjects, vagal blocking therapy sustained 22% excess weight loss (7% total body weight loss) and improvements in glycemic control and blood pressure at 24 months.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Observational / Cohort
Participants
28
View on DOI

Cite this study

Shikora, S. A., Toouli, J., Herrera, M. F., Kulseng, B., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., & Billingto, C. J. (2016). Intermittent Vagal Nerve Block for Improvements in Obesity, Cardiovascular Risk Factors, and Glycemic Control in Patients with Type 2 Diabetes Mellitus: 2-Year Results of the VBLOC DM2 Study. Obesity Surgery, 26(5), 1021-1028. https://doi.org/10.1007/s11695-015-1914-1

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.